Vera Therapeutics, Inc.
VERA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831828
In the last 90 days, Vera Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 219 institutions reported holding it in 13F filings for Q2 2026, worth $3.34B in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Vera Therapeutics, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 0 | 22 | +22 |
| Shares | 0 | 14.5M | +14.5M |
| Value | $0 | $186.1M | +$186.1M |
New holders (22)
Institutions that held Vera Therapeutics, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sofinnova Investments, Inc. | 2,914,776 | $38.6M | 2.35% |
| Abingworth LLP | 2,960,231 | $38.5M | 11.91% |
| FMR LLC | 3,122,512 | $38.5M | 0.00% |
| Citadel Advisors LLC | 1,738,693 | $22.2M | 0.02% |
| KPCB XVI Associates, LLC | 1,343,152 | $16.0M | 7.38% |
| Octagon Capital Advisors LP | 1,132,671 | $15.0M | 3.11% |
| Alphabet Inc. | 944,791 | $12.5M | 0.26% |
| Millennium Management LLC | 81,452 | $1.08M | 0.00% |
| Parkman Healthcare Partners LLC | 75,638 | $1.00M | 0.22% |
| Vanguard Group Inc | 52,268 | $693.0K | 0.00% |
| Monashee Investment Management LLC | 46,069 | $611.0K | 0.07% |
| Caas Capital Management LP | 20,000 | $265.0K | 0.01% |
| Raymond James Financial Services Advisors, Inc. | 17,828 | $236.0K | 0.00% |
| Geode Capital Management, LLC | 16,076 | $213.0K | 0.00% |
| Maven Securities LTD | 13,000 | $178.0K | 0.02% |
| ExodusPoint Capital Management, LP | 12,841 | $170.0K | 0.00% |
| Goldman Sachs Group Inc | 11,747 | $156.0K | 0.00% |
| Bank of America Corp | 6,212 | $82.0K | 0.00% |
| Morgan Stanley | 1,784 | $24.0K | 0.00% |
| UBS Group AG | 956 | $13.0K | 0.00% |
| BlackRock Inc. | 593 | $8.00K | 0.00% |
| Wells Fargo & Company | 28 | $0 | 0.00% |
Sold out (0)
Institutions that held Vera Therapeutics, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
None.